Business
Change of Name Effective
Change of Name Effective.
About this update from Niox Group Plc
[{"type":"text","content":"\n \n \n RNS Number : 6507L\n Circassia Pharmaceuticals Plc\n 01 May 2020\n \n \n \n \n Change of Name Effective\n \n \n Oxford, UK - 1 May 2020:\n Circassia Group plc (\"Circassia\" or \"the Company\"; LSE: CIR), a specialty biopharmaceutical company focused on respiratory disease, today confirms that, further to the announcement of 30 April 2020, its change of name has taken effect. The Company's TIDM remains CIR and the Company's website address continues to be \n \n www.circassia.com\n \n .\n \n \n \n \n \n Contacts\n \n \n \n \n \n \n \n \n Circassia\n \n \n Ian Johnson, Executive Chairman\n \n \n Michael Roller, Chief Financial Officer\n \n \n \n \n \n \n \n c/o Peel Hunt\n \n \n \n \n \n \n \n \n \n Peel Hunt (Nominated Adviser and Joint Broker)\n \n \n James Steel / Oliver Jackson\n \n \n \n \n \n \n \n Tel: +44 (0) 20 7418 8900\n \n \n \n \n \n \n \n \n \n finnCap (Joint Broker)\n \n \n Geoff Nash / Alice Lane\n \n \n \n \n Tel: +44 (0) 20 7220 0500\n \n \n \n \n \n \n Numis Securities (Joint Broker)\n \n \n James Black / Duncan Monteith\n \n \n \n \n Tel: +44 (0) 20 7260 1000\n \n \n \n \n \n \n \n \n \n \n \n \n \n This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.\n END\n \n CANFIFFAETILIII\n ","length":4396,"tagName":"div"}]